A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology.

Proliferation of innovative procedures and treatments in surgery has led to novel and distinct ethical challenges. Medicine can learn from plastic surgeons’ approaches to informed consent and potentially harmful treatments.

The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.

The government is justified in using eminent domain to purchase patents in order to produce large amounts of medication during a public health crisis.

A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior.

Distinctions between treatment and enhancement, and between supposedly authentic and inauthentic tools, often inform judgments about what is morally acceptable in sport.

Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based.